Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-14-001629
Filing Date
2014-11-14
Accepted
2014-11-14 16:58:19
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 SIGNPATH PHARMA INC. 10Q 2014-09-30 signpath.htm 10-Q 518917
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN signpathexh311.htm EX-31.1 15765
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN signpathexh321.htm EX-32.1 8420
  Complete submission text file 0001096906-14-001629.txt   2965417

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT sppxbrl-20140930.xml EX-101.INS 470618
5 XBRL SCHEMA DOCUMENT sppxbrl-20140930.xsd EX-101.SCH 30639
6 XBRL CALCULATION LINKBASE DOCUMENT sppxbrl-20140930_cal.xml EX-101.CAL 12567
7 XBRL DEFINITION LINKBASE DOCUMENT sppxbrl-20140930_def.xml EX-101.DEF 28728
8 XBRL LABELS LINKBASE DOCUMENT sppxbrl-20140930_lab.xml EX-101.LAB 114453
9 XBRL PRESENTATION LINKBASE DOCUMENT sppxbrl-20140930_pre.xml EX-101.PRE 99391
Mailing Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951
Business Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951 267-772-0107
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-158474 | Film No.: 141225180
SIC: 2834 Pharmaceutical Preparations